학술논문

Partial agonists of dopamine receptors: clinical effects and dopamine receptor interactions in combining aripiprazole with a full antagonist in treating psychosis.
Document Type
Article
Source
BJPsych Advances. Mar2023, Vol. 29 Issue 2, p158-165. 8p.
Subject
*DOPAMINE agonists
*DOPAMINE receptors
*ARIPIPRAZOLE
*PROLACTINOMA
*PSYCHOSES
*WEIGHT gain
Language
ISSN
2056-4678
Abstract
SUMMARY: Partial agonists of dopamine receptors are used in combination with full antagonists in treating psychosis, either to mitigate side-effects or in the hope of increasing effectiveness. We examine how combinations may affect the occupancy of D2/D3 dopamine receptors and explore how these can explain the outcomes in the light of the dopamine hypothesis of psychosis. The combinations considered here are from published studies combining aripiprazole with amisulpride, with risperidone in people with hyperprolactinaemia and with olanzapine to mitigate weight gain. We discuss possible worsening of symptoms by the addition of a partial agonist or switching. We also examine the potentially adverse interaction with a full antagonist such as haloperidol given during a subsequent relapse to control severe agitation. [ABSTRACT FROM AUTHOR]